# Isthmic tubal ectopic pregnancy from a partial molar pregnancy: A case report and literature review

**Authors:** Richard Q. Vuong, Molly Hurd, Zeynep Tek, Nicole Brzozowski

PMC · DOI: 10.1016/j.crwh.2025.e00736 · Case Reports in Women's Health · 2025-07-22

## TL;DR

A rare case of a tubal ectopic pregnancy caused by a partial molar pregnancy is reported, highlighting the importance of accurate diagnosis and follow-up care.

## Contribution

The paper presents a rare case of isthmic tubal ectopic pregnancy due to a partial hydatidiform mole and reviews recent literature on tubal molar pregnancies.

## Key findings

- A 41-year-old woman was diagnosed with an isthmic tubal ectopic pregnancy secondary to a partial hydatidiform mole.
- Thirteen cases of tubal molar pregnancies were reported between 2019 and 2024.
- Ancillary studies like immunohistochemistry and MRI are recommended for accurate diagnosis of molar ectopic pregnancies.

## Abstract

While tubal ectopic pregnancies and molar pregnancies are relatively common, tubal molar pregnancies are exceptionally rare, with an estimated incidence of 1.5 per 1,000,000 pregnancies. Molar pregnancies are at risk for developing malignant gestational trophoblastic neoplasia (15–20 % for complete hydatidiform moles and 0.5–6 % for partial hydatidiform moles) and warrant robust diagnostic workup to determine appropriate management. Presented here is a case of an isthmic tubal ectopic pregnancy secondary to a partial hydatidiform mole; additionally, a literature review through PubMed discusses all tubal molar pregnancies reported within a 5-year period.

A 41-year-old woman (gravida 2, para 0, aborta 1) at 6 weeks and 5 days of gestation presented to the emergency department from the outpatient clinic because prenatal ultrasound did not show an intrauterine pregnancy and her a β-hCG level was 17,913 mIU/mL. Due to concern for ectopic pregnancy, she underwent diagnostic laparoscopy, which revealed an unruptured right isthmic tubal ectopic gestation. The specimen was removed and sent for histological evaluation, which confirmed a partial hydatidiform mole that stained positive for p57; the finding was supported by molecular studies. The patient was discharged the same day and follow-up β-hCG levels were monitored weekly until undetectable. The literature review found that 13 tubal molar pregnancies had been reported between 2019 and 2024.

Histopathologic examination of gestational trophoblastic disease should be supported by ancillary studies such as immunohistochemical, flow cytometry, and molecular analyses to ensure accurate diagnosis. Magnetic resonance imaging could offer a way to preoperatively diagnose molar ectopic pregnancy in select hemodynamically stable patients.

•Ectopic pregnancies secondary to hydatidiform molar gestations are overdiagnosed.•Immunohistochemistry should support the diagnosis of molar ectopic pregnancy.•Magnetic resonance imaging may provide a preoperative diagnosis of molar ectopic pregnancy.•Thirteen tubal molar pregnancies were reported in the literature from September 2019 to March 2024.•Monitoring of β-hCG levels and contraception counseling are critical after molar pregnancy.

Ectopic pregnancies secondary to hydatidiform molar gestations are overdiagnosed.

Immunohistochemistry should support the diagnosis of molar ectopic pregnancy.

Magnetic resonance imaging may provide a preoperative diagnosis of molar ectopic pregnancy.

Thirteen tubal molar pregnancies were reported in the literature from September 2019 to March 2024.

Monitoring of β-hCG levels and contraception counseling are critical after molar pregnancy.

## Linked entities

- **Diseases:** ectopic pregnancy (MONDO:0000755), hydatidiform mole (MONDO:0006248)

## Full-text entities

- **Genes:** CDKN1C (cyclin dependent kinase inhibitor 1C) [NCBI Gene 1028] {aka BWCR, BWS, KIP2, WBS, p57, p57Kip2}, HTC2 (hypertrichosis 2 (generalized, congenital)) [NCBI Gene 3342] {aka CGH, CXINSq27.1, HCG}
- **Diseases:** CHM (MESH:D006828), GTD (MESH:D031901), moles (MESH:D009506), blood loss (MESH:D016063), abdominal pain (MESH:D015746), pelvic pain (MESH:D017699), urinary tract infection (MESH:D014552), hemoperitoneum (MESH:D006465), ectopic tubal pregnancy (MESH:D011274), pregnancies (MESH:D011254), bleeding (MESH:D006470), tubal ectopics (MESH:D005184), nausea (MESH:D009325), choriocarcinoma (MESH:D002822), D'Asta (MESH:D014808), pain (MESH:D010146), vaginal bleeding (MESH:D014592), fibroids (MESH:D007889), malignancy (MESH:D009369), post-molar trophoblastic disease (MESH:D014328), infection (MESH:D007239), hydatidiform molar gestations (MESH:D016640), ectopic pregnancies (MESH:D011271), vomiting (MESH:D014839)
- **Chemicals:** Hematoxylin (MESH:D006416), methotrexate (MESH:D008727), nitrofurantoin (MESH:D009582), ibuprofen (MESH:D007052), eosin (MESH:D004801)
- **Species:** Homo sapiens (human, species) [taxon 9606], Enterococcus faecalis (species) [taxon 1351]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12312042/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12312042/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12312042/full.md

---
Source: https://tomesphere.com/paper/PMC12312042